Goodwill and Other Intangible Assets

3 Months Ended

Mar. 31, 2013

Goodwill and Other Intangible Assets

5. Goodwill and Other Intangible Assets

Our goodwill as of March 31, 2013 and December 31, 2012, by reporting segment, consist of the following:

	Medical		Technical and		Sales		Corporate
	Equipment		Professional		and		and
(in thousands)	Outsourcing		Services		Remarketing		Unallocated		Total

Balance at December 31, 2011	$	251,653	$	55,655	$	18,603	$	—	$	325,911
Acquisitions	9,666		—		—		—		9,666
Balance at December 31, 2012	261,319		55,655		18,603		—		335,577
Acquisitions	—		—		—		—		—
Balance at March 31, 2013	$	261,319	$	55,655	$	18,603	$	—	$	335,577

Our other intangible assets as of March 31, 2013 and December 31, 2012 consist of the following:

	March 31, 2013							December 31, 2012
			Accumulated							Accumulated
(in thousands)	Cost		Amortization			Net		Cost		Amortization			Net

Finite-life intangibles
Customer relationship	$	115,731	$	(63,141	)	$	52,590	$	115,731	$	(60,368	)	$	55,363
Supply agreement	26,000		(14,381		)	11,619		26,000		(13,655		)	12,345
Technology databases	7,217		(7,145		)	72		7,217		(7,127		)	90
Non-compete agreements	780		(247		)	533		780		(203		)	577
Favorable lease agreements	134		(120		)	14		134		(118		)	16
Total finite-life intangibles	149,862		(85,034		)	64,828		149,862		(81,471		)	68,391
Indefinite-life intangibles
Trade names	166,000		—			166,000		166,000		—			166,000
Total intangible assets	$	315,862	$	(85,034	)	$	230,828	$	315,862	$	(81,471	)	$	234,391

Total amortization expense related to intangible assets for the three months ended March 31, 2013 and 2012 was $3.6 and $4.1 million, respectively.

The estimated future amortization expense for identifiable intangible assets during the remainder of 2013 and the next five years is as follows:

(in thousands)

Remainder of 2013	$	10,190
2014	12,835
2015	11,930
2016	10,805
2017	7,514
2018	5,931

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details